Review Article
Other versions:
- ContentsContents
- Article InfoArticle Info
- CiteCite
- MetricsMetrics
- CommentComment
- RelatedRelated
- FigsFigs
- TabsTabs
- RefsRefs
- CitedCited
-
Article title
-
Abstract
-
Keywords
-
Disease – COVID-19
-
Flow
-
Laboratory characteristics of COVID-19 complications
-
-
Etiological agent – SARS-CoV-2
-
Cause of mortality
-
Cytokine storm
-
The aberrant activated NLRP3 inflammasome cause the cytokine storm
-
Can SARS-CoV-2 activate NLRP3 inflammasome?
-
Which cells are responsible for the development of the cytokine storm?
-
Why does SARS-CoV-2 spread so easily?
-
Is there a connection between viral load, replication and the hyperactivation of NLRP3 inflammasome?
-
You are patient with confirmed Covid-19 - what doing?
-
World Health Organization recommendations for Covid-19 treatment
-
Outpatients treatment
-
Molnupinavir (Lagevrio)
-
Remdesivir
-
Inpatient treatment
-
Tocilizumab and sarilumab
-
Baricitinib
-
Remdesivir is with weak or conditional recommendation in favour
-
Price list of WHO-recommended Medicines
-
-
Treatment of Covid-19 with inhaled bromhexine, higher doses of colchicine and hymecromone
-
Why Bromhexine hydrochloride?
-
What are the results so far for treating COVID-19 with BHH?
-
What accounts for the discrepancy between expected and actual results in the use of BHH for the treatment of COVID-19?
-
When and how to apply BHH to achieve maximum effect in the treatment of COVID-19
-
Colchicine
-
Colchicine properties and mechanisms of action
-
Colchicine accumulates in leukocytes!
-
Why attempts to prove a curative effect of colchicine against COVID-19 have failed?
-
Our therapeutic regimen
-
Mortality in 452 inpatients treated with higher colchicine doses was about 5 times lower than the control group
-
Are the higher doses of colchicine dangerous?
-
Colchicine toxicity in drug-drug interactions
-
Hymecromone inhibits the hyaluronan synthesis and storm
-
-
-
Acknowledgements
-
References
Subscribe to email alerts for current Article's categories